
11 - 50 employees
Founded 2021
🧬 Biotechnology
🔬 Science
🤝 B2B
đź’° $45M Series A - Spear Bio on 2024-07
Biotechnology • Science • B2B
Spear Bio is a biotechnology company that develops and sells ultra-sensitive protein biomarker detection assays and related reagents and services. Their proprietary SPEAR UltraDetect technology uses a two-factor authenticated, homogeneous (wash-free) format to detect trace protein biomarkers in single-molecule ranges from ultra-small sample volumes, and they offer assay kits (e. g. , pTau217, pTau231, GFAP, NF-L), reaction kits, automation accessories, data analysis, and evaluation/research accelerator services for applications in neurology, immunology, and infectious disease research.
đź•’ June 18
Business Development Manager introducing ultra-sensitive Immunoassays to Life Sciences and CRO markets in EMEA. Seeking top talent with a strong network and sales track record.
🇪🇺 Europe – Remote
đź’° $45M Series A - Spear Bio on 2024-07
⏰ Full Time
🟡 Mid-level
đźź Senior
đź’° Business Development (BDR)